
Japson Pharmaceuticals (Pb) Limited
Provides medical services since 1983, based in Manimajra, Chandigarh.
Provides medical services since 1983, based in Manimajra, Chandigarh.
Japson Pharmaceuticals (Pb) Limited (JPPL) is a Public Limited Indian Non-Government Company incorporated in India on 16 June 1983 and has a history of 41 years and ten months. Its registered office is in Chandigarh, Chandigarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 6.50 M.
The company currently has active open charges totaling ₹7.25 M. The company has closed loans amounting to ₹3.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pervesh Bir, Abhay Barnala, and Angad Pratap serve as directors at the Company.
Chandigarh, Chandigarh, India
+91-XXXXXXXXXX
U24232CH1983PLC005474
005474
Public Limited Indian Non-Government Company
16 Jun 1983
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chandigarh
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pervesh Bir | Additional Director | 25-Jan-2024 | Current |
Abhay Barnala ![]() | Director | 03-May-2019 | Current |
Angad Pratap ![]() | Director | 03-May-2019 | Current |
Japson Pharmaceuticals (Pb) Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 101.36% decrease in profit. The company's net worth dipped by a decrease of 0.18%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Japson Pharmaceuticals (Pb) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹7.25 M
₹34.85 M
Date | Lender | Amount | Status |
---|---|---|---|
02 Feb 1987 | Sbi | ₹3.10 M | Open |
17 Aug 1985 | S B C | ₹4.15 M | Open |
20 Jan 1988 | State Bnak Of India | ₹1.45 M | Satisfied |
09 Jun 1987 | Panjab Financial Corporantion | ₹3.00 M | Satisfied |
12 Mar 1987 | Panjab State Industrial Development Corpo Ltd | ₹3.85 M | Satisfied |
Unlock and access historical data on people associated with Japson Pharmaceuticals (Pb), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Japson Pharmaceuticals (Pb), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Japson Pharmaceuticals (Pb)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pervesh Bir was appointed as a Additional Director was appointed as a Additional Director on 25 Jan 2024 & has been associated with this company since 1 year 3 months .
Japson Pharmaceuticals (Pb) Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Japson Pharmaceuticals (Pb) Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
Abhay Barnala was appointed as a Director was appointed as a Director on 03 May 2019 & has been associated with this company since 6 years 12 days .
Angad Barnala Pratap was appointed as a Director was appointed as a Director on 03 May 2019 & has been associated with this company since 6 years 12 days .
A charge registered on 09 Jun 1987 via Charge ID 90176446 with Panjab Financial Corporantion was fully satisfied on 12 Jun 2017.
Japson Pharmaceuticals (Pb) Limited was incorporated on 16 Jun 1983.
The authorized share capital of Japson Pharmaceuticals (Pb) Limited is ₹ 8.00 M and paid-up capital is ₹ 6.50 M.
Currently 3 directors are associated with Japson Pharmaceuticals (Pb) Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Japson Pharmaceuticals (Pb) Limited is 6328, Ground Floor Rajiv Vihar, Manimajra, Chandigarh, India, 160101.
The corporate identification number (CIN) of Japson Pharmaceuticals (Pb) Limited is U24232CH1983PLC005474 and the company number is 005474 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2021 indicates that The net worth of Japson Pharmaceuticals (Pb) Limited has experienced an downturn of -0.18%.
As per the financial statements for fiscal Year 2021, The total open charges for Japson Pharmaceuticals (Pb) Limited amount to ₹ 7.25 M.
The most recent Balance Sheet for Japson Pharmaceuticals (Pb) Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
MN
JB
SA
RK